CAS: 2490599-18-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GMB-475 REF: IN-DA01V70PCAS: 2490599-18-1 | 98% | To inquire | Wed 20 Nov 24 |
 | GMB-475 REF: TM-T8488CAS: 2490599-18-1 | 100% - 98.78% | 95.00 €~2,270.00 € | Wed 27 Nov 24 |
 | GMB-475 REF: 10-F840929CAS: 2490599-18-1 | 95% | To inquire | Mon 02 Dec 24 |
Ref: IN-DA01V70P
| 1mg | 57.00 € | ||
| 5mg | 92.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 146.00 € | ||
| 50mg | 251.00 € |
Estimated delivery in United States, on Wednesday 20 Nov 2024
GMB-475
CAS:2490599-18-1
GMB-475, a PROTAC-based BCR-ABL1 inhibitor, tackles drug resistance by promoting VHL-mediated degradation.
Formula:
C43H46F3N7O7S
Purity:
100% - 98.78%
Color and Shape:
Solid
Molecular weight:
861.93
- Inhibitors
- Bcr-Abl
- Apoptosis
- Cytoskeletal Signaling
- See more categories
- Protacs and Impurities
Ref: TM-T8488
| 1mg | 95.00 € | ||
| 5mg | 196.00 € | ||
| 10mg | 343.00 € | ||
| 25mg | 580.00 € | ||
| 50mg | 822.00 € | ||
| 100mg | 1,112.00 € | ||
| 500mg | 2,270.00 € | ||
| 1mL*10mM (DMSO) | 273.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
Ref: 10-F840929
| 5mg | 199.00 € | ||
| 10mg | 304.00 € | ||
| 25mg | To inquire | ||
| 50mg | 755.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
